Annual CFF
$6.86 M
+$7.36 M+1472.20%
31 December 2023
Summary:
STRATA Skin Sciences annual cash flow from financing activities is currently $6.86 million, with the most recent change of +$7.36 million (+1472.20%) on 31 December 2023. During the last 3 years, it has risen by +$4.32 million (+169.48%). SSKN annual CFF is now -83.92% below its all-time high of $42.67 million, reached on 31 December 2015.SSKN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$1.94 M
+$1.94 M+100.00%
30 September 2024
Summary:
STRATA Skin Sciences quarterly cash flow from financing activities is currently $1.94 million, with the most recent change of +$1.94 million (+100.00%) on 30 September 2024. Over the past year, it has increased by +$2.05 million (+1968.27%). SSKN quarterly CFF is now -95.42% below its all-time high of $42.40 million, reached on 30 June 2015.SSKN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$1.93 M
+$2.05 M+1677.87%
30 September 2024
Summary:
STRATA Skin Sciences TTM cash flow from financing activities is currently $1.93 million, with the most recent change of +$2.05 million (+1677.87%) on 30 September 2024. Over the past year, it has dropped by -$4.44 million (-69.74%). SSKN TTM CFF is now -96.58% below its all-time high of $56.29 million, reached on 30 June 2015.SSKN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SSKN Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1472.2% | +1968.3% | -69.7% |
| 3 y3 years | +169.5% | +2012.0% | +1650.0% |
| 5 y5 years | -39.3% | +100.0% | +100.0% |
SSKN Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1472.2% | -72.1% | +488.6% | -71.9% | +485.0% |
| 5 y | 5 years | -39.3% | +1472.2% | -72.1% | +488.6% | -71.9% | +485.0% |
| alltime | all time | -83.9% | +480.5% | -95.4% | +130.2% | -96.6% | +195.8% |
STRATA Skin Sciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.94 M(>+9900.0%) | $1.93 M(-1677.9%) |
| June 2024 | - | $0.00(-100.0%) | -$122.00 K(-101.8%) |
| Mar 2024 | - | -$18.00 K(<-9900.0%) | $6.84 M(-0.3%) |
| Dec 2023 | $6.86 M(-1472.2%) | $0.00(-100.0%) | $6.86 M(+7.9%) |
| Sept 2023 | - | -$104.00 K(-101.5%) | $6.36 M(-1.6%) |
| June 2023 | - | $6.96 M(>+9900.0%) | $6.46 M(-1393.0%) |
| Mar 2023 | - | $0.00(-100.0%) | -$500.00 K(0.0%) |
| Dec 2022 | -$500.00 K(-643.5%) | -$500.00 K(<-9900.0%) | -$500.00 K(<-9900.0%) |
| Sept 2022 | - | $0.00(0.0%) | $0.00(-100.0%) |
| June 2022 | - | $0.00(0.0%) | $92.00 K(0.0%) |
| Dec 2021 | $92.00 K(-96.4%) | $0.00(-100.0%) | $92.00 K(-16.4%) |
| Sept 2021 | - | $92.00 K(+411.1%) | $110.00 K(-95.7%) |
| Dec 2020 | $2.55 M(-960.1%) | $18.00 K(>+9900.0%) | $2.55 M(+14.1%) |
| Sept 2020 | - | $0.00(-100.0%) | $2.23 M(0.0%) |
| June 2020 | - | $2.53 M(-954.1%) | $2.23 M(-854.1%) |
| Dec 2019 | -$296.00 K(-102.6%) | -$296.00 K(<-9900.0%) | -$296.00 K(<-9900.0%) |
| Sept 2019 | - | $0.00(0.0%) | $0.00(-100.0%) |
| June 2019 | - | $0.00(0.0%) | -$51.00 K(-100.5%) |
| Dec 2018 | $11.31 M(-727.1%) | $0.00(-100.0%) | $11.31 M(+6.0%) |
| Sept 2018 | - | -$51.00 K(-100.4%) | $10.66 M(+9.3%) |
| June 2018 | - | $11.66 M(-3899.7%) | $9.76 M(-585.4%) |
| Mar 2018 | - | -$307.00 K(-52.2%) | -$2.01 M(+11.5%) |
| Dec 2017 | -$1.80 M(-254.5%) | -$642.00 K(-33.1%) | -$1.80 M(+50.9%) |
| Sept 2017 | - | -$960.00 K(+850.5%) | -$1.20 M(+265.4%) |
| June 2017 | - | -$101.00 K(+1.0%) | -$327.00 K(-0.3%) |
| Mar 2017 | - | -$100.00 K(+194.1%) | -$328.00 K(-128.1%) |
| Dec 2016 | $1.17 M(-97.3%) | -$34.00 K(-63.0%) | $1.17 M(-23.5%) |
| Sept 2016 | - | -$92.00 K(-9.8%) | $1.52 M(-2.7%) |
| June 2016 | - | -$102.00 K(-107.3%) | $1.57 M(-96.4%) |
| Mar 2016 | - | $1.40 M(+330.6%) | $44.06 M(+3.3%) |
| Dec 2015 | $42.67 M(+68.4%) | $324.00 K(-761.2%) | $42.67 M(+0.7%) |
| Sept 2015 | - | -$49.00 K(-100.1%) | $42.35 M(-24.8%) |
| June 2015 | - | $42.40 M(>+9900.0%) | $56.29 M(+305.5%) |
| Mar 2015 | - | $0.00(-100.0%) | $13.88 M(-45.2%) |
| Dec 2014 | $25.34 M | $8000.00(-99.9%) | $25.34 M(-17.5%) |
| Sept 2014 | - | $13.88 M(<-9900.0%) | $30.72 M(+195.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2014 | - | -$8700.00(-100.1%) | $10.41 M(-0.5%) |
| Mar 2014 | - | $11.46 M(+112.9%) | $10.46 M(-49.0%) |
| Dec 2013 | $20.52 M(+291.1%) | $5.38 M(-183.8%) | $20.52 M(+19.0%) |
| Sept 2013 | - | -$6.42 M(<-9900.0%) | $17.25 M(-36.0%) |
| June 2013 | - | $43.30 K(-99.8%) | $26.98 M(+0.9%) |
| Mar 2013 | - | $21.52 M(+917.6%) | $26.74 M(+409.6%) |
| Dec 2012 | $5.25 M(-65.1%) | $2.11 M(-35.9%) | $5.25 M(-71.1%) |
| Sept 2012 | - | $3.30 M(-1794.8%) | $18.17 M(+22.2%) |
| June 2012 | - | -$194.60 K(-771.0%) | $14.87 M(-1.3%) |
| Mar 2012 | - | $29.00 K(-99.8%) | $15.07 M(+0.2%) |
| Dec 2011 | $15.04 M(-27.4%) | $15.04 M(>+9900.0%) | $15.04 M(<-9900.0%) |
| Sept 2011 | - | $0.00(0.0%) | -$15.00 K(-100.1%) |
| June 2011 | - | $0.00(0.0%) | $15.37 M(+0.8%) |
| Mar 2011 | - | $0.00(-100.0%) | $15.25 M(-26.3%) |
| Dec 2010 | $20.70 M(-36.8%) | -$15.00 K(-100.1%) | $20.70 M(-34.6%) |
| Sept 2010 | - | $15.39 M(<-9900.0%) | $31.65 M(-17.1%) |
| June 2010 | - | -$117.00 K(-102.1%) | $38.16 M(-0.1%) |
| Mar 2010 | - | $5.45 M(-50.2%) | $38.21 M(+16.6%) |
| Dec 2009 | $32.76 M(+196.3%) | $10.93 M(-50.1%) | $32.76 M(+49.8%) |
| Sept 2009 | - | $21.90 M(<-9900.0%) | $21.87 M(+99.5%) |
| June 2009 | - | -$70.60 K(-3169.6%) | $10.96 M(-0.9%) |
| Mar 2009 | - | $2300.00(-94.7%) | $11.06 M(+0.0%) |
| Dec 2008 | $11.06 M(+2.1%) | $43.80 K(-99.6%) | $11.06 M(+0.4%) |
| Sept 2008 | - | $10.99 M(>+9900.0%) | $11.01 M(+2.5%) |
| June 2008 | - | $24.70 K(>+9900.0%) | $10.74 M(-0.0%) |
| Mar 2008 | - | $0.00(-100.0%) | $10.75 M(-0.8%) |
| Dec 2007 | $10.83 M(-14.2%) | -$5300.00(-100.0%) | $10.83 M(-53.7%) |
| Sept 2007 | - | $10.72 M(>+9900.0%) | $23.39 M(+84.2%) |
| June 2007 | - | $29.20 K(-65.8%) | $12.70 M(+0.2%) |
| Mar 2007 | - | $85.30 K(-99.3%) | $12.68 M(+0.5%) |
| Dec 2006 | $12.62 M(-28.9%) | $12.55 M(>+9900.0%) | $12.62 M(>+9900.0%) |
| Sept 2006 | - | $31.30 K(+226.0%) | $69.00 K(+83.0%) |
| June 2006 | - | $9600.00(-65.8%) | $37.70 K(+34.2%) |
| Mar 2006 | - | $28.10 K | $28.10 K |
| Dec 2005 | $17.76 M(+82.5%) | - | - |
| Dec 2004 | $9.73 M | - | - |
FAQ
- What is STRATA Skin Sciences annual cash flow from financing activities?
- What is the all time high annual CFF for STRATA Skin Sciences?
- What is STRATA Skin Sciences annual CFF year-on-year change?
- What is STRATA Skin Sciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for STRATA Skin Sciences?
- What is STRATA Skin Sciences quarterly CFF year-on-year change?
- What is STRATA Skin Sciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for STRATA Skin Sciences?
- What is STRATA Skin Sciences TTM CFF year-on-year change?
What is STRATA Skin Sciences annual cash flow from financing activities?
The current annual CFF of SSKN is $6.86 M
What is the all time high annual CFF for STRATA Skin Sciences?
STRATA Skin Sciences all-time high annual cash flow from financing activities is $42.67 M
What is STRATA Skin Sciences annual CFF year-on-year change?
Over the past year, SSKN annual cash flow from financing activities has changed by +$7.36 M (+1472.20%)
What is STRATA Skin Sciences quarterly cash flow from financing activities?
The current quarterly CFF of SSKN is $1.94 M
What is the all time high quarterly CFF for STRATA Skin Sciences?
STRATA Skin Sciences all-time high quarterly cash flow from financing activities is $42.40 M
What is STRATA Skin Sciences quarterly CFF year-on-year change?
Over the past year, SSKN quarterly cash flow from financing activities has changed by +$2.05 M (+1968.27%)
What is STRATA Skin Sciences TTM cash flow from financing activities?
The current TTM CFF of SSKN is $1.93 M
What is the all time high TTM CFF for STRATA Skin Sciences?
STRATA Skin Sciences all-time high TTM cash flow from financing activities is $56.29 M
What is STRATA Skin Sciences TTM CFF year-on-year change?
Over the past year, SSKN TTM cash flow from financing activities has changed by -$4.44 M (-69.74%)